These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 12601454)
1. [Monitoring of 131I incorporation in nuclear medicine personnel by self accomplished measurements]. Hänscheid H; Lassmann M; Aulbach F; Reiners C Nuklearmedizin; 2003 Feb; 42(1):45-9. PubMed ID: 12601454 [TBL] [Abstract][Full Text] [Related]
2. [Incorporation monitoring of employees of a radioiodine therapy ward. Is incorporation monitoring required for routine?]. Happel C; Kratzel U; Selkinski I; Bockisch B; Etzel M; Korkusuz H; Sauter B; Staudt J; von Müller F; Grünwald F; Kranert WT Nuklearmedizin; 2013; 52(1):43-50. PubMed ID: 23348688 [TBL] [Abstract][Full Text] [Related]
3. A methodology for auto-monitoring of internal contamination by 131I in nuclear medicine workers. Vidal MV; Dantas AL; Dantas BM Radiat Prot Dosimetry; 2007; 125(1-4):483-7. PubMed ID: 17766259 [TBL] [Abstract][Full Text] [Related]
4. 131I INTERNAL CONTAMINATION AND COMMITTED DOSE ASSESSMENT AMONG NUCLEAR MEDICINE MEDICAL PERSONNEL. Brudecki K; Kluczewska-Galka A; Mróz T; Jarzab B; Zagrodzki P; Janowski P Radiat Prot Dosimetry; 2018 May; 179(3):275-281. PubMed ID: 29237081 [TBL] [Abstract][Full Text] [Related]
5. METHOD FOR OCCUPATIONAL SKIN DOSE ESTIMATION IN UPPER EXTREMITY 131I-MIBG CONTAMINATION. Magill D; Beckmann N; Felice M; Harkins M Radiat Prot Dosimetry; 2018 Oct; 181(3):214-220. PubMed ID: 29432588 [TBL] [Abstract][Full Text] [Related]
6. Uncertainties in determination of 131I activity in thyroid gland. Ośko J; Golnik N; Pliszczynski T Radiat Prot Dosimetry; 2007; 125(1-4):516-9. PubMed ID: 17309877 [TBL] [Abstract][Full Text] [Related]
7. Establishing a threshold for 131I bioassay in nuclear medicine personnel. Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711 [TBL] [Abstract][Full Text] [Related]
8. [Exposure of relatives of patients after stationary radioiodine therapy by inhalation of 131I in their homes]. Wellner U; Eschner W; Hillger HW; Schicha H Nuklearmedizin; 1998 May; 37(3):113-9. PubMed ID: 9604232 [TBL] [Abstract][Full Text] [Related]
9. An investigation into internal exposure management needs for nuclear medicine practitioners and temporary visitors through I-131 internal dose assessment: Focusing on large hospitals in South Korea. Kim ST; Yoo JR; Park JM PLoS One; 2018; 13(12):e0209244. PubMed ID: 30566458 [TBL] [Abstract][Full Text] [Related]
10. [Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases]. Lassmann M; Hänscheid H; Schelper LF; Körber C; Reiners C Nuklearmedizin; 1998 May; 37(3):120-3. PubMed ID: 9604233 [TBL] [Abstract][Full Text] [Related]
11. Calibration of surface contamination monitors for the detection of iodine incorporation in the thyroid gland. Bailat C; Buchillier T; Baechler S; Bochud F Radiat Prot Dosimetry; 2011 Mar; 144(1-4):505-9. PubMed ID: 21149292 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers. Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174 [TBL] [Abstract][Full Text] [Related]
14. ASSESSMENT OF INTAKE ACCORDING TO IDEAS GUIDANCE: CASE STUDY. Bitar A; Maghrabi M Radiat Prot Dosimetry; 2018 Apr; 179(2):179-183. PubMed ID: 29145639 [TBL] [Abstract][Full Text] [Related]
15. Assessment of intake and internal dose from iodine-131 for exposed workers handling radiopharmaceutical products. Bitar A; Maghrabi M; Doubal AW Appl Radiat Isot; 2013 Dec; 82():370-5. PubMed ID: 24184740 [TBL] [Abstract][Full Text] [Related]
16. Assessment of annual whole-body occupational radiation exposure in medical practice in Ghana (2000-09). Hasford F; Owusu-Banahene J; Amoako JK; Otoo F; Darko EO; Emi-Reynolds G; Yeboah J; Arwui CC; Adu S Radiat Prot Dosimetry; 2012 May; 149(4):431-7. PubMed ID: 21743072 [TBL] [Abstract][Full Text] [Related]
17. Determination of uncertainties associated to the in vivo measurement of iodine-131 in the thyroid. Dantas BM; Lima FF; Dantas AL; Lucena EA; Gontijo RM; Carvalho CB; Hazin C Appl Radiat Isot; 2016 Jul; 113():1-4. PubMed ID: 27108067 [TBL] [Abstract][Full Text] [Related]
18. [Incorporation Monitoring of Staff using I-131 and Lu-177 in a Nuclear Medicine Ward]. Wanke C; Szemerski B; Geworski L Nuklearmedizin; 2022 Aug; 61(4):333-338. PubMed ID: 35388445 [TBL] [Abstract][Full Text] [Related]
19. DEVELOPMENT AND IMPLEMENTATION OF TOOLS FOR SELF-MONITORING OF STAFF EXPOSED TO 131I IN NUCLEAR MEDICINE CENTRES OF CHILE. Díaz-Londoño G; García M; Astudillo R; Hermosilla A Radiat Prot Dosimetry; 2017 Apr; 173(4):302-307. PubMed ID: 26842826 [TBL] [Abstract][Full Text] [Related]
20. [Internal contamination of hospital nuclear medicine personnel by iodine-131]. Chahed N; Mtimet S; Hammami H; Mhiri A Tunis Med; 1998; 76(8-9):234-8. PubMed ID: 9810858 [No Abstract] [Full Text] [Related] [Next] [New Search]